Jung-Chool Kim
Chief Executive Officer at APROGEN BIOLOGICS INC.
Net worth: 1 M $ as of 2024-04-29
Profile
Jung-Chool Kim is currently the Chief Executive Officer & Director at Aprogen Biologics, Inc. since 2012.
He is also a Director at Aprogen, Inc. and E&M Revolution Co., Ltd.
Additionally, he has previously worked as the Chief Executive Officer at Chunggei Pharm Co. Ltd.
and as a Director at Aprogen, Inc. and Aprogen Biologics, Inc. (Korea).
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
APROGEN, INC
0.42% | 2024-04-13 | 1,123,427 ( 0.42% ) | 1 M $ | 2024-04-29 |
APROGEN BIOLOGICS
0.00% | 2024-03-27 | 2,188 ( 0.00% ) | 2 523 $ | 2024-04-29 |
Jung-Chool Kim active positions
Companies | Position | Start |
---|---|---|
APROGEN BIOLOGICS INC. | Chief Executive Officer | 2012-03-31 |
APROGEN MEDICINES INC. | Director/Board Member | - |
E&M Revolution Co., Ltd.
E&M Revolution Co., Ltd. Pharmaceuticals: MajorHealth Technology E & M Revolution Co., Ltd. is a South Korean company that manufactures pharmaceutical products. The CEO of the private company is Soon-Kyu Park. | Director/Board Member | - |
Former positions of Jung-Chool Kim
Companies | Position | End |
---|---|---|
Aprogen Biologics, Inc. (Korea)
Aprogen Biologics, Inc. (Korea) BiotechnologyHealth Technology Aprogen Biologics, Inc. engages in the production of bacterial and virus vaccines. The company is headquartered in Seongnam, South Korea. | Director/Board Member | - |
Aprogen, Inc. /Old/
Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Aprogen, Inc. engages in the development and manufacture of biopharmaceutical products. Its product portfolio includes new biotherapeutics and biosimilar products. The company was founded by Jae-Seob Kim on April 4, 2000 and is headquartered in Seongnam-si, South Korea. | Director/Board Member | - |
Chunggei Pharm Co. Ltd. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
APROGEN BIOLOGICS INC. | Health Technology |
APROGEN MEDICINES INC. | Health Technology |
Private companies | 4 |
---|---|
Chunggei Pharm Co. Ltd. | Health Technology |
E&M Revolution Co., Ltd.
E&M Revolution Co., Ltd. Pharmaceuticals: MajorHealth Technology E & M Revolution Co., Ltd. is a South Korean company that manufactures pharmaceutical products. The CEO of the private company is Soon-Kyu Park. | Health Technology |
Aprogen Biologics, Inc. (Korea)
Aprogen Biologics, Inc. (Korea) BiotechnologyHealth Technology Aprogen Biologics, Inc. engages in the production of bacterial and virus vaccines. The company is headquartered in Seongnam, South Korea. | Health Technology |
Aprogen, Inc. /Old/
Aprogen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Aprogen, Inc. engages in the development and manufacture of biopharmaceutical products. Its product portfolio includes new biotherapeutics and biosimilar products. The company was founded by Jae-Seob Kim on April 4, 2000 and is headquartered in Seongnam-si, South Korea. | Health Technology |
- Stock Market
- Insiders
- Jung-Chool Kim